opex guidanc combin downward asp pressur
keep us neutral even procedur growth continu strong
report result in-lin
compani prior pre-announc limit surpris investor
previous note revenu came btig/street estim vs
led strength revenu beat price
unit placement note china saw bolu unit sale ahead tariff
increas lift unit net china benefit system
would slightli multi-system sale result ep
pre-announc consensu estim
estim
fundament continu feel gain good adopt gensurg
continu strong adopt ou view multipl headwind
may limit share current valuat gensurg grow expect revenue per case
trend lower higher benign procedur compris higher total
procedur addit system like also trend lower increas
leas lower trade-in activ expect yet see impact
competit impact meaning competit system like
lower delay purchas decis commerci
spend ramp see invest year limit ep growth
invest stem competit encroach collect feel
off-set greater unit placement procedur grow nice
mid-teen addit lever growth sp ion addit indic continu
measur earli contribut above-ment cross current
combin premium valuat share leav us maintain neutral
multipl pipelin product forthcom continu deep pipelin
immedi impact come on-going roll-out phase
launch sp instal base stand unit end sp
continu grow well held back lack third indic
us expans colorect still expect fda desir
trial includ follow-up timelin growth delay ion
growth track system field addit public
way synchros product launch limit
basi look updat
detail around guidanc origin guid
procedur growth management provid increment color around
leas expect increas trade-in like level declin
like see downward pressur less multi-system sale
revenu per procedur like also see downward pressur
view proport gener surgeri procedur continu grow
line gm expect fall declin
midpoint larg come lower price new
product opex expect grow deceler rate
tax rate expect
bp increas midpoint
valuat rate neutral risk discuss
idc btig estim compani document
million except per share amount
long-term potenti robot surgeri look favor gener surgeri exceed expect drive xi
sale dvp improv like due watch wait patient come back surgeri eu procedur jump
indic dvp may sweet spot curv platform value-ori custom howev
ntm ep recent expens grow would wait share come back attract entri
competit announc launch
roll-out ion endolumin platform da vinci sp
model in-lin isrg procedur guidanc oper
expens growth base case assum revenu growth
driven higher proport procedur volum higher unit
placement off-set lower lower revenu per procedur
improv economi capital-expenditure environ
slowdown procedur growth
slump economi capital-expenditure environ
manufactur market da vinci
surgic system relat
instrument accessori
intuit surgic report system place fourth quarter consensu estim
system sold us sold japan sold europ sold rest world
place system unit ship oper leas arrang system trade
system quarter higher q/q higher
greater proport ou sale favor mix xi system quarter trade-in high compani
report system sale top estim consensuss estim
procedur growth quarter higher forecast consensu estim
report procedur asp flat vs prior quarter report instrument revenu slightli
estim consensu estim servic revenu rel line
forecast consensu forecast total revenu quarter vs estim
consensu estim
 gross margin bp model oper spend basi level
forecast sg spend percentag revenu bp higher expect spend bp
higher overal isrg ebit margin bp lower estim non- ep came
actualsbtig estimate varianc da vinci system procedur growth bp system revenu instrument revenu servic revenu revenu cog sg expens expens incom gross bp sg spend bp spend bp ebit bp tax bpssourc btig estim compani filingsvari
make follow chang model
within procedur revenu mix increas procedur expect close
align management commentari procedur guidanc system increas system
unit number modestli account higher proport leas expect come quarter lower
price system close align management commentari around potenti come
success year expect revenu per procedur trend growth benign procedur
put pressur procedur said overal revenu off-set higher procedur growth previou
expect lower servic margin servic declin modestli past
two quarter endoscopi repair impact segment slightli lower product gm better
reflect management guidanc overal fall within management guidanc
 tweak sg cost better meet management guidanc oper expens
growth beyond adjust interest expens fall within management guidanc
rais previous model tax rate ad progress share repurchas
expect execut share repurchas beyond overal ep expect move
close reflect transit year invest growth ahead materi competit
rate neutral continu out-performance like procedur trade ntm
ep almost med tech think stock ultim trade earn earn growth btig
provid price target neutral-r stock
revenu incom adjust volum btig estim compani filingsnewold chang
incom etot y/i sale oper interest incom tax non-controlling incom share adjust net adjust oper expens ep btig estim compani report
enu eda vinci sale rest y/i asp asp realiz inc stock enu y/i vinci instal base da vinci da vinci da vinci da vinci instal y/i seq seq procedur procedures/instal enuetot world-wide y/i y/i singl y/i multisit singl blend report stock enu per stock enu instrument enu y/i enue/procedur inc y/i train enu instal base per train enu y/i enu y/i gross profit product product gross profit servic servic btig estim compani report
procedur eu procedur estim gyn dvh y/i y/i multi y/i singl y/i y/i y/i y/i y/i y/i dvp y/i y/i y/i y/i y/i surgeri includ ent cardiac vascular y/i y/i y/i y/i y/i y/i y/i y/i cardiac y/i y/i multi y/i singl y/i y/i surgeri inc y/i gener y/i y/i world-wide y/i seq btig estim compani report
procedur eou procedur estim y/i eu y/i y/i gastric y/i y/i eu y/i y/i y/i world-wide y/i seq btig estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
